17-75765021-T-G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_000154.2(GALK1):c.116A>C(p.Asn39Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000151 in 1,458,364 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000154.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000838 AC: 2AN: 238552Hom.: 0 AF XY: 0.00000767 AC XY: 1AN XY: 130440
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1458364Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 725378
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Deficiency of galactokinase Uncertain:1
This sequence change replaces asparagine with threonine at codon 39 of the GALK1 protein (p.Asn39Thr). The asparagine residue is moderately conserved and there is a small physicochemical difference between asparagine and threonine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with GALK1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at